Dong W. Jeon
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Impact of Age on Antiplatelet Monotherapy in the Chronic Maintenance Period After Percutaneous Coronary Intervention: A Post Hoc Analysis From the HOST-EXAM Extended Study.
Journal: The Canadian journal of cardiology
Published: July 10, 2023
Lipid-Lowering Efficacy of Combination Therapy With Moderate-Intensity Statin and Ezetimibe Versus High-Intensity Statin Monotherapy: A Randomized, Open-Label, Non-Inferiority Trial From Korea.
Journal: Journal of lipid and atherosclerosis
Published: April 08, 2023
Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice.
Journal: The Korean journal of internal medicine
Published: March 16, 2023
Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function.
Journal: JACC. Asia
Published: June 06, 2022
Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI".
Journal: Korean circulation journal
Published: June 03, 2022
Public Reporting on the Quality of Care in Patients with Acute Myocardial Infarction: The Korean Experience.
Journal: International journal of environmental research and public health
Published: November 29, 2021
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial.
Journal: Korean circulation journal
Published: September 24, 2021
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI.
Journal: Korean circulation journal
Published: August 30, 2021
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
Journal: Lancet (London, England)
Published: April 09, 2021
Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO).
Journal: Clinical hypertension
Published: February 17, 2021
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study.
Journal: Clinical therapeutics
Published: November 11, 2020
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction.
Journal: JACC. Cardiovascular interventions
Published: August 24, 2020
Last Updated: 09/26/2026